Today’s pharmacists face both a clinical and ethical dilemma surrounding the medical use of a DEA Schedule I drug: marijuana, or specifically, one of its components, cannabidiol (CBD). CBD is a plant-derived compound from Cannabis sativa, the species of plant that includes both hemp and marijuana. In the United States, CBD is marketed in a range of consumer products—food and beverages, OTCsupplements, personal care products, and cosmetics—that are subject to FDA regulation. Marketed consumer products containing plant-based CBD are either hemp-derived or marijuana-derived. This article summarizes the differences between the three types of cannabidiol (CBD) products. The author discusses the pharmacological properties, benefits, and risks of CBD, how to choose a high-quality hemp derived CBD product, and dosing and adverse effects CBD oil.
At the completion of this knowledge-based activity, the participant will be able to:
- Summarize the differences between the three types of cannabidiol (CBD) products.
- List the dosing instructions and adverse effects of Epidiolex (cannabidiol oil).
- List the criteria for choosing a high-quality hemp derived CBD product.
- Discuss the pharmacological properties of CBD.
- Identify the benefits and risks of CBD products.
Activity Type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 1
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-246-H01-P.
To obtain credit for To CBD or Not to CBD? The Research of the Uses, Benefits, and Risks of CBD Oil: What Pharmacists Need to Know, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted. The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.
Initial release date: August 1, 2020
Expiration date: August 1, 2023 - No credit can be earned after this date
To CBD or Not to CBD? The Research of the Uses, Benefits, and Risks of CBD Oil: What Pharmacists Need to Know is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association. © 2020 American Pharmacists Association
Merrill Norton, PharmD, DPh, ICCDP-D, Kathleen Collins, PharmD, BCPS, Hannah Holloway, Madeline Marsh, Minna Hassanand, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-20-246-H01-P||0.2 CEUs||August 01, 2020 - August 01, 2023|